Table 4.
Covariate | Estimate | Standard error | Wald chi-square | Hazard ratio | P value |
Disease-free survival (month)1 | |||||
Fractionated ER | −0.13960 | 0.05628 | 6.1530 | 0.870 | 0.0131 |
Fractionated PR | −0.10107 | 0.05869 | 2.9655 | 0.904 | 0.0851 |
Age <36 years | 0.67577 | 0.29191 | 5.3592 | 1.966 | 0.0206 |
Lymph node ≥10 | 1.35863 | 0.27997 | 23.5496 | 3.891 | <0.0001 |
Histology grade III | 1.32154 | 0.61828 | 4.5687 | 3.749 | 0.0326 |
AJCC stage | 0.91674 | 0.18495 | 24.5675 | 2.501 | <0.0001 |
Overall survival (month)2 | |||||
Fractionated PR | −0.21830 | 0.06066 | 12.9512 | 0.804 | 0.0003 |
Lymph node 1–9 | 0.81272 | 0.30782 | 6.9707 | 2.254 | 0.0083 |
Lymph node ≥10 | 1.56278 | 0.33739 | 21.4549 | 4.772 | <0.0001 |
Histology grade III | 0.68063 | 0.25213 | 7.2875 | 1.975 | 0.0069 |
Tumor size (cm) | 0.32670 | 0.16657 | 3.8469 | 1.386 | 0.0498 |
Neoadjuvant or adjuvant chemotherapy | 0.61693 | 0.35181 | 3.0750 | 1.853 | 0.0795 |
Time lag since recurrence | 0.07444 | 0.00775 | 92.2451 | 1.077 | <0.0001 |
Cox’s proportional hazard model: n=416, adjusted generalized R 2=0.2486
Cox’s proportional hazard model: n=416, adjusted generalized R 2=0.3971